IOPIDINE 1% (APRACLONIDINE HYDROCHLORIDE OPHTHALMIC SOLUTION)
IOPIDINE 1% (APRACLONIDINE HYDROCHLORIDE OPHTHALMIC SOLUTION) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: IOPIDINE 1%; Generic name: APRACLONIDINE HYDROCHLORIDE OPHTHALMIC SOLUTION; Manufacturer: Harrow Eye, LLC.
| Brand name | IOPIDINE 1% |
|---|---|
| Generic name | APRACLONIDINE HYDROCHLORIDE OPHTHALMIC SOLUTION |
| Manufacturer | Harrow Eye, LLC |
| Used for | INDICATIONS AND USAGE IOPIDINE 1% Ophthalmic Solution is indicated to control or prevent post-surgical elevations in IOP that occur in patients after argon laser trabeculoplasty, argon laser iridotomy or Nd:YAG posterior capsulotomy. |
| Dosage | DOSAGE AND ADMINISTRATION One drop of IOPIDINE* 1% Ophthalmic Solution should be instilled in the scheduled operative eye one hour before initiating anterior segment laser surgery and a second drop should be instilled to the same eye immediately upon completion of the laser surgical procedure. Use a separate container for each single‑drop dose and discard each container after use. |
| Warnings | WARNINGS FOR TOPICAL OPHTHALMIC USE ONLY. Not for injection or oral ingestion. Topical administration of apraclonidine have been reported to cause cardiovascular collapse requiring intubation and ventilation in pediatric patients 6 years and younger, including neonates. Systemic adverse reactions such as prolonged lethargy and unresponsiveness, apnea, hypoxia, respiratory failure, bradycardia, hypertension, hypotension, hypothermia, hypotonia, pallor have also been reported. Appropriate monitori |
| Active ingredient(s) | APRACLONIDINE HYDROCHLORIDE |
| Route | OPHTHALMIC |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=00f18845-ccde-8678-e063-6294a90a3374 |